Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
CONCLUSION: Our study indicates that in patients with a functioning kidney allograft > 5 years, pre-transplant AT1R antibodies may be associated with a greater risk of rejection and late graft failure.
PMID: 32870149 [PubMed - as supplied by publisher]
Source: Clinical Nephrology - Category: Urology & Nephrology Authors: Aziz F, Jung-Hynes B, Parajuli S, Redfield RR, Astor BC, Mandelbrot D, Hidalgo L, Djamali A Tags: Clin Nephrol Source Type: research
More News: Bone Graft | Kidney Transplant | Kidney Transplantation | Study | Transplant Surgery | Transplants | Urology & Nephrology